Anixa Biosciences CEO Kumar Amit bought 5,000 shares at $2.76 each, bringing his reported holding to 662,000 shares. The purchase represents about 0.8% of his resulting stake and gives investors a specific view of the chief executive’s ownership position in Anixa Biosciences.

Key Highlights

  • Kumar Amit’s reported Anixa Biosciences ownership reached 662,000 shares after the transaction.
  • The purchase was dated 10 September 2026 and carried transaction code P.
  • The acquired shares represented about 0.8% of Amit’s resulting holding.

Anixa Biosciences Inc (NASDAQ: ANIX) CEO Kumar Amit bought 5,000 shares at $2.76 per share. The purchase gives the chief executive a reported post-transaction holding of 662,000 shares.

Transaction Details and Ownership

Anixa Biosciences Inc identified Kumar Amit, its chief executive officer, as the purchaser. The transaction involved 5,000 shares at $2.76 per share and was dated 10 September 2026. It carried SEC transaction code P. Amit’s reported ownership after the transaction stood at 662,000 shares of Anixa Biosciences Inc. The acquired shares represented about 0.8% of his resulting shareholding.

What the Ownership Figures Show

The 662,000-share figure represents Amit’s reported position after the purchase. The 0.8% measure applies to the acquired shares against that resulting holding. Code P is the SEC transaction code reported for the purchase. The disclosed figures identify both the size of the trade and the CEO’s resulting ownership position in Anixa Biosciences. Transaction code P denotes an open-market or private purchase.